Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.
Press releases published on May 8, 2025
Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2025 Results
GlobeNewswire
·
May 8, 2025
MANCHESTER, N.H., May 08, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced …
Seamless Therapeutics Expands Board of Directors with Appointment of Alvin Shih
GlobeNewswire
·
May 8, 2025
Dresden, Germany, and Lexington, MA, May 8, 2025 – Seamless Therapeutics, today announced the appointment of Alvin Shih, M.D., M.B.A., as an Independent Director to its Board. Dr. Shih is an experienced drug developer and physician with a track record of …
ProQR Announces First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer …
Kaltura Announces Financial Results for First Quarter 2025
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Kaltura, Inc. (“Kaltura” or the “Company”), the video experience cloud, today announced financial results for the first quarter ended March 31, 2025, as well as outlook for the second quarter and full year 2025. " …
Fred Ball Joins Axonius Board of Directors to Drive Financial and Global Expansion
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the appointment of Fred Ball to its Board of Directors. Ball, a veteran finance …
Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference
GlobeNewswire
·
May 8, 2025
HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Monte Rosa Therapeutics Announces First Quarter 2025 Financial Results and Business Updates
GlobeNewswire
·
May 8, 2025
VAV1-directed MRT-6160 program advancing toward multiple Phase 2 studies, enabled by Phase 1 SAD/MAD study data supporting broad potential application in immune-mediated diseases MRT-2359 Phase 1/2 study data demonstrate encouraging signals of clinical …
BigCommerce Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
AUSTIN, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce” or the “Company”) (Nasdaq: BIGC), an open SaaS, composable ecommerce platform for fast-growing and established B2C and B2B brands, retailers, manufacturers and …
Surge Copper Delivers Geotechnical Results Supporting Pit Design and Resource Growth at Berg
GlobeNewswire
·
May 8, 2025
PFS-level geotechnical program completed under budget; results support steeper pit walls, lower strip ratio, and highlight resource expansion potential Vancouver, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: …
ChampionX Declares Quarterly Dividend
GlobeNewswire
·
May 8, 2025
THE WOODLANDS, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- ChampionX Corporation (Nasdaq: CHX) (“ChampionX”) announced today its Board of Directors has declared a regular quarterly dividend of $0.095 per share on the company’s common stock, par value $0.01 per …
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Revenue from the Advanced Energy segment increased 6% in Q1 2025 compared with the same period last year U.S. single use handpiece revenue grew 14% in Q1 2025 compared with the same period last year Preparing for a planned launch of the AYON™ Body …
Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
Initiation of Phase 3 AURORA trial of Descartes-08 in myasthenia gravis expected in 2Q25; deep and sustained benefits observed through Month 12 after a single course of therapy in Phase 2b trial Preliminary data from Phase 2 trial of Descartes-08 in …
Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 8, 2025
– WTX-124 Phase 1/1b clinical trial on track for data readouts and interactions with the FDA in the second half of the year – – First patient dosed in the Phase 1b/2 clinical trial of WTX-330, seeking to build on the clinical activity and tolerability …
Aduro Clean Technologies and Cleanfarms Sign Memorandum of Understanding to Collaborate on Development of Commercial Pathway for Challenging Agricultural Plastics
GlobeNewswire
·
May 8, 2025
LONDON, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste …
Shock Top: A Bold Rebrand for a Craft Beer Icon
GlobeNewswire
·
May 8, 2025
PORTLAND, Ore., May 08, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), known for its bold flavors and unfiltered wheat ales, today announced a transformative rebrand. With …
Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems
GlobeNewswire
·
May 8, 2025
MINNEAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced a meaningful step forward for children facing fluid overload …
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1 study in active, difficult-to-treat rheumatoid arthritis to initiate in Q2 2025 CLN-978 expands into Sjögren’s disease; Phase 1 study in active, moderate to severe patients …
Tecnoglass Reports Record First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
- Record First Quarter Revenue of $222.3 Million, Up 15.4% Year-Over-Year Driven Entirely by Double Digit Organic Growth in Both Residential and Multi-Family/Commercial Projects - - Single-Family Residential Revenue Increased to a First Quarter Record $88. …
Cielo Issues Letter to Shareholders
GlobeNewswire
·
May 8, 2025
CALGARY, Alberta, May 08, 2025 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) (“Cielo” or the “Company”) is pleased to have issued today a letter to shareholders, as below: Dear Shareholders, Thank you to all those who …
Ligand Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
First quarter performance driven by strong portfolio royalty revenue growth of 44% Strengthened commercial portfolio and pipeline through strategic transactions with Channel Therapeutics and Castle Creek Biosciences Reiterating 2025 financial guidance of $ …